Skip to main content
francesco-dazzi

Professor Francesco Dazzi

Vice Dean (International) and Head of Regenerative Medicine

Research interests

  • Biomedical and life sciences

Biography

Professor Francesco Dazzi has been working on the biology and clinical applications of cellular therapies in haemopoietic stem cell transplantation for the last 20 years. He obtained an MD and a PhD at Padua University Medical School (Italy) and subsequently trained as a Haematologist at Verona University and at the Royal Postgraduate Medical School (London, UK). He was appointed Senior Lecturer and then Professor in Stem Cell Biology at Imperial College in 2005. In 2014 he moved to King’s College London where he is Professor of Regenerative & Haematological Medicine and leads Cellular Therapies for Kings’ Health Partners.

Francesco pioneered a large and highly successful cellular immunotherapy programme for leukaemia and characterised the immunosuppressive effects of mesenchymal stromal cells (MSC). His team successfully tested MSC in pre-clinical models and the work has formed the basis of UK wide clinical studies.

Professor Dazzi was appointed to the role of Vice-Dean (International) for the Faculty of Life Sciences & Medicine in 2019.

    Research

    Immunology and Immunotherapy Programme Header
    Cancer Immunology & Immunotherapy

    Cancer Immunology represents a broad field of research that studies host-tumour interactions as therapeutic targets in the treatment of cancer.

    Project status: Ongoing

    Spotlight

    Spotlight on COVID: Targeting the immune response

    Professor Francesco Dazzi discusses targeting the COVID-induced cytokine storm

    spotlight-covid-1920

      Research

      Immunology and Immunotherapy Programme Header
      Cancer Immunology & Immunotherapy

      Cancer Immunology represents a broad field of research that studies host-tumour interactions as therapeutic targets in the treatment of cancer.

      Project status: Ongoing

      Spotlight

      Spotlight on COVID: Targeting the immune response

      Professor Francesco Dazzi discusses targeting the COVID-induced cytokine storm

      spotlight-covid-1920